Vital Signs is a podcast series focused on investing, hosted by Senior Health and Biotech journalist Nadine McGrath.
In this episode Nadine chats to Aroa Biosurgery (ASX:ARX) VP of Medical Affairs Dr Adam Young about what drew him to the company’s soft tissue regenerating technology and to delve deeper into the company.
Dr Young has a fascinating background across med and biotech, so listen in to hear about his intrigue towards Aroa, its scientific rigour, what separates its technology from the shortcomings of others, and how it can be rolled out towards a large patient base.
This podcast was developed in collaboration with Aroa Biosurgery, a Stockhead advertiser at the time of publishing.
The interviews and discussions in this podcast are opinions only and not financial or investment advice. Listeners should obtain independent advice based on their own circumstances before making any financial decisions.
You might be interested in